{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T00:59:53Z","timestamp":1772931593102,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,6]]},"DOI":"10.7759\/cureus.104798","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T05:48:26Z","timestamp":1772862506000},"source":"Crossref","is-referenced-by-count":0,"title":["Beyond Donor-Specific Antibodies: The Unseen Role of Non-Donor-Specific Anti-human Leukocyte Antigen (HLA) Antibodies in Rejection"],"prefix":"10.7759","author":[{"given":"Pranjal","family":"Kashiv","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish","family":"Balwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit S","family":"Pasari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek","family":"Kute","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1802677","article-title":"Antibody-mediated rejection of solid-organ allografts","volume":"379","author":"Loupy A","year":"2018","unstructured":"Loupy A, Lefaucheur C. Antibody-mediated rejection of solid-organ allografts. N Engl J Med. 2018, 379:1150-60. 10.1056\/NEJMra1802677","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajt.2023.10.016","article-title":"The Banff 2022 Kidney Meeting Report: Reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics","volume":"24","author":"Naesens M","year":"2024","unstructured":"Naesens M, Roufosse C, Haas M, et al.. The Banff 2022 Kidney Meeting Report: Reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics. Am J Transplant. 2024, 24:338-49. 10.1016\/j.ajt.2023.10.016","journal-title":"Am J Transplant"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15074","article-title":"Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: clinical presentation and implications for outcome","volume":"19","author":"Senev A","year":"2019","unstructured":"Senev A, Coemans M, Lerut E, et al.. Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: clinical presentation and implications for outcome. Am J Transplant. 2019, 19:763-80. 10.1111\/ajt.15074","journal-title":"Am J Transplant"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3889\/oamjms.2018.162","article-title":"The spectrum of histopathological changes in the renal allograft - a 12 months protocol biopsy study","volume":"6","author":"Severova-Andreevska G","year":"2018","unstructured":"Severova-Andreevska G, Grcevska L, Petrushevska G, et al.. The spectrum of histopathological changes in the renal allograft - a 12 months protocol biopsy study. Open Access Maced J Med Sci. 2018, 6:606-12. 10.3889\/oamjms.2018.162","journal-title":"Open Access Maced J Med Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/lt.25286","article-title":"Class II human leukocyte antigen epitope mismatch predicts de novo donor-specific antibody formation after liver transplantation","volume":"24","author":"Kubal CA","year":"2018","unstructured":"Kubal CA, Mangus R, Ekser B, et al.. Class II human leukocyte antigen epitope mismatch predicts de novo donor-specific antibody formation after liver transplantation. Liver Transpl. 2018, 24:1101-8. 10.1002\/lt.25286","journal-title":"Liver Transpl"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016070797","article-title":"Antibody-mediated rejection due to preexisting versus de novo donor-specific antibodies in kidney allograft recipients","volume":"28","author":"Aubert O","year":"2017","unstructured":"Aubert O, Loupy A, Hidalgo L, et al.. Antibody-mediated rejection due to preexisting versus de novo donor-specific antibodies in kidney allograft recipients. J Am Soc Nephrol. 2017, 28:1912-23. 10.1681\/ASN.2016070797","journal-title":"J Am Soc Nephrol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy A","year":"2013","unstructured":"Loupy A, Lefaucheur C, Vernerey D, et al.. Complement-binding anti-HLA antibodies and kidney-allograft survival. N Engl J Med. 2013, 369:1215-26. 10.1056\/NEJMoa1302506","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012070664","article-title":"Donor-specific antibodies adversely affect kidney allograft outcomes","volume":"23","author":"Mohan S","year":"2012","unstructured":"Mohan S, Palanisamy A, Tsapepas D, et al.. Donor-specific antibodies adversely affect kidney allograft outcomes. J Am Soc Nephrol. 2012, 23:2061-71. 10.1681\/ASN.2012070664","journal-title":"J Am Soc Nephrol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01686.x","article-title":"Determinants of poor graft outcome in patients with antibody-mediated acute rejection","volume":"7","author":"Lefaucheur C","year":"2007","unstructured":"Lefaucheur C, Nochy D, Hill GS, Suberbielle-Boissel C, Antoine C, Charron D, Glotz D. Determinants of poor graft outcome in patients with antibody-mediated acute rejection. Am J Transplant. 2007, 7:832-41. 10.1111\/j.1600-6143.2006.01686.x","journal-title":"Am J Transplant"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13192","article-title":"HLA epitopes as viewed by antibodies: what is it all about?","volume":"15","author":"Tambur AR","year":"2015","unstructured":"Tambur AR, Claas FH. HLA epitopes as viewed by antibodies: what is it all about?. Am J Transplant. 2015, 15:1148-54. 10.1111\/ajt.13192","journal-title":"Am J Transplant"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15898","article-title":"The Banff 2019 kidney meeting report (I): updates on and clarification of criteria for T cell- and antibody-mediated rejection","volume":"20","author":"Loupy A","year":"2020","unstructured":"Loupy A, Haas M, Roufosse C, et al.. The Banff 2019 kidney meeting report (I): updates on and clarification of criteria for T cell- and antibody-mediated rejection. Am J Transplant. 2020, 20:2318-31. 10.1111\/ajt.15898","journal-title":"Am J Transplant"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/462507-beyond-donor-specific-antibodies-the-unseen-role-of-non-donor-specific-anti-human-leukocyte-antigen-hla-antibodies-in-rejection","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T05:48:27Z","timestamp":1772862507000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/462507-beyond-donor-specific-antibodies-the-unseen-role-of-non-donor-specific-anti-human-leukocyte-antigen-hla-antibodies-in-rejection"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.104798","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,6]]}}}